Literature DB >> 21511878

Common genetic variants, QT interval, and sudden cardiac death in a Finnish population-based study.

Peter A Noseworthy1, Aki S Havulinna, Kimmo Porthan, Annukka M Lahtinen, Antti Jula, Pekka J Karhunen, Markus Perola, Lasse Oikarinen, Kimmo K Kontula, Veikko Salomaa, Christopher Newton-Cheh.   

Abstract

BACKGROUND: Although sudden cardiac death (SCD) is heritable, its genetic underpinnings are poorly characterized. The QT interval appears to have a graded relationship to SCD, and 35% to 45% of its variation is heritable. We examined the relationship among recently reported common genetic variants, QT interval, and SCD. METHODS AND
RESULTS: We genotyped 15 common (minor allele frequency >1%) candidate single nucleotide polymorphisms (SNPs), based on association with the QT interval in prior studies, in individuals in 2 cohort studies (Health 2000, n = 6597; Mini-Finland, n = 801). After exclusions, we identified 116 incident SCDs from the remaining sample (n = 6808). We constructed a QT genotype score (QT(score)) using the allele copy number and previously reported effect estimates for each SNP. Cox proportional hazards models adjusting for age, sex, and geographical area were used for time to SCD analyses. The QT(score) was a continuous independent predictor of the heart rate-corrected QT interval (P<10(-107)). Comparing the top with the bottom quintile of QT(score), there was a 15.6-ms higher group mean QT interval (P<10(-84)). A 10-ms increase in the observed QT interval was associated with an increased risk of SCD (hazard ratio, 1.19; 95% confidence interval, 1.07 to 1.32; P = 0.002). There was no linear relationship between QT(score) and SCD risk; although in post hoc secondary analysis there was increased risk in the top compared with the middle QT(score) quintile (hazard ratio, 1.92; 95% confidence interval, 1.05 to 3.58; P = 0.04).
CONCLUSIONS: Our study strongly replicates the relationship between common genetic variants and the QT interval and confirms the relationship between the QT interval and SCD but does not show evidence for a linear relationship between QT(score) and SCD risk.

Entities:  

Mesh:

Year:  2011        PMID: 21511878      PMCID: PMC3119024          DOI: 10.1161/CIRCGENETICS.110.959049

Source DB:  PubMed          Journal:  Circ Cardiovasc Genet        ISSN: 1942-3268


  41 in total

Review 1.  Genetic determinants of sudden cardiac death.

Authors:  Peter A Noseworthy; Christopher Newton-Cheh
Journal:  Circulation       Date:  2008-10-28       Impact factor: 29.690

2.  Repolarization reserve: a moving target.

Authors:  Dan M Roden
Journal:  Circulation       Date:  2008-09-02       Impact factor: 29.690

3.  Short QT syndrome: clinical findings and diagnostic-therapeutic implications.

Authors:  Carla Giustetto; Fernando Di Monte; Christian Wolpert; Martin Borggrefe; Rainer Schimpf; Pascal Sbragia; Gianpiero Leone; Philippe Maury; Olli Anttonen; Michel Haissaguerre; Fiorenzo Gaita
Journal:  Eur Heart J       Date:  2006-08-22       Impact factor: 29.983

4.  Common NOS1AP variants are associated with a prolonged QTc interval in the Rotterdam Study.

Authors:  Albert-Jan L H J Aarnoudse; Christopher Newton-Cheh; Paul I W de Bakker; Sabine M J M Straus; Jan A Kors; Albert Hofman; André G Uitterlinden; Jacqueline C M Witteman; Bruno H C Stricker
Journal:  Circulation       Date:  2007-06-18       Impact factor: 29.690

5.  Association of NOS1AP genetic variants with QT interval duration in families from the Diabetes Heart Study.

Authors:  Allison B Lehtinen; Christopher Newton-Cheh; Julie T Ziegler; Carl D Langefeld; Barry I Freedman; Kurt R Daniel; David M Herrington; Donald W Bowden
Journal:  Diabetes       Date:  2008-01-30       Impact factor: 9.461

6.  Associations between genetic variants in the NOS1AP (CAPON) gene and cardiac repolarization in the old order Amish.

Authors:  Wendy Post; Haiqing Shen; Coleen Damcott; Dan E Arking; W H Linda Kao; Paul A Sack; Kathleen A Ryan; Aravinda Chakravarti; Braxton D Mitchell; Alan R Shuldiner
Journal:  Hum Hered       Date:  2007-06-12       Impact factor: 0.444

7.  Identification of a common variant at the NOS1AP locus strongly associated to QT-interval duration.

Authors:  Mark Eijgelsheim; Adrianus L H J Aarnoudse; Fernando Rivadeneira; Jan A Kors; Jacqueline C M Witteman; Albert Hofman; Cornelia M van Duijn; André G Uitterlinden; Bruno H C Stricker
Journal:  Hum Mol Genet       Date:  2008-10-16       Impact factor: 6.150

8.  Gender and effects of a common genetic variant in the NOS1 regulator NOS1AP on cardiac repolarization in 3761 individuals from two independent populations.

Authors:  Martin D Tobin; Mika Kähönen; Peter Braund; Tuomo Nieminen; Cother Hajat; Maciej Tomaszewski; Jari Viik; Rami Lehtinen; G Andre Ng; Peter W Macfarlane; Paul R Burton; Terho Lehtimäki; Nilesh J Samani
Journal:  Int J Epidemiol       Date:  2008-05-29       Impact factor: 7.196

9.  Projections of global mortality and burden of disease from 2002 to 2030.

Authors:  Colin D Mathers; Dejan Loncar
Journal:  PLoS Med       Date:  2006-11       Impact factor: 11.069

10.  Multiple independent genetic factors at NOS1AP modulate the QT interval in a multi-ethnic population.

Authors:  Dan E Arking; Amit Khera; Chao Xing; W H Linda Kao; Wendy Post; Eric Boerwinkle; Aravinda Chakravarti
Journal:  PLoS One       Date:  2009-01-30       Impact factor: 3.240

View more
  26 in total

1.  Epidemiology and genetics of sudden cardiac death.

Authors:  Rajat Deo; Christine M Albert
Journal:  Circulation       Date:  2012-01-31       Impact factor: 29.690

2.  Long QT syndrome type 5-Lite: Defining the clinical phenotype associated with the potentially proarrhythmic p.Asp85Asn-KCNE1 common genetic variant.

Authors:  Conor M Lane; John R Giudicessi; Dan Ye; David J Tester; Ram K Rohatgi; J Martijn Bos; Michael J Ackerman
Journal:  Heart Rhythm       Date:  2018-04-03       Impact factor: 6.343

3.  Common Genetic Variant Risk Score Is Associated With Drug-Induced QT Prolongation and Torsade de Pointes Risk: A Pilot Study.

Authors:  David G Strauss; Jose Vicente; Lars Johannesen; Ksenia Blinova; Jay W Mason; Peter Weeke; Elijah R Behr; Dan M Roden; Ray Woosley; Gulum Kosova; Michael A Rosenberg; Christopher Newton-Cheh
Journal:  Circulation       Date:  2017-02-17       Impact factor: 29.690

4.  Prevalence of arrhythmia-associated gene mutations and risk of sudden cardiac death in the Finnish population.

Authors:  Annukka M Lahtinen; Aki S Havulinna; Peter A Noseworthy; Antti Jula; Pekka J Karhunen; Markus Perola; Christopher Newton-Cheh; Veikko Salomaa; Kimmo Kontula
Journal:  Ann Med       Date:  2013-05-08       Impact factor: 4.709

5.  A common variant near the KCNJ2 gene is associated with T-peak to T-end interval.

Authors:  Annukka Marjamaa; Lasse Oikarinen; Kimmo Porthan; Samuli Ripatti; Gina Peloso; Peter A Noseworthy; Matti Viitasalo; Markku S Nieminen; Lauri Toivonen; Kimmo Kontula; Leena Peltonen; Aki S Havulinna; Antti Jula; Christopher J O'Donnell; Christopher Newton-Cheh; Markus Perola; Veikko Salomaa
Journal:  Heart Rhythm       Date:  2012-02-15       Impact factor: 6.343

Review 6.  The genetics of sudden cardiac death.

Authors:  Dan E Arking; Nona Sotoodehnia
Journal:  Annu Rev Genomics Hum Genet       Date:  2012-06-11       Impact factor: 8.929

Review 7.  Cardiovascular safety of prokinetic agents: A focus on drug-induced arrhythmias.

Authors:  J R Giudicessi; M J Ackerman; M Camilleri
Journal:  Neurogastroenterol Motil       Date:  2018-02-14       Impact factor: 3.598

Review 8.  Genetics of sudden cardiac death caused by ventricular arrhythmias.

Authors:  Roos F Marsman; Hanno L Tan; Connie R Bezzina
Journal:  Nat Rev Cardiol       Date:  2013-12-10       Impact factor: 32.419

9.  Oral contraceptive use and the ECG: evidence of an adverse QT effect on corrected QT interval.

Authors:  Tara Sedlak; Chrisandra Shufelt; Carlos Iribarren; Liisa L Lyon; C Noel Bairey Merz
Journal:  Ann Noninvasive Electrocardiol       Date:  2013-05-03       Impact factor: 1.468

Review 10.  The cardiac sodium channel gene SCN5A and its gene product NaV1.5: Role in physiology and pathophysiology.

Authors:  Christiaan C Veerman; Arthur A M Wilde; Elisabeth M Lodder
Journal:  Gene       Date:  2015-09-08       Impact factor: 3.688

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.